New Naphthalene Derivatives from Heliotropium ovalifolium Forssk

 

A Suthar*, V Gaja, G Pardeshi, K Katkar, V Naik, T Mane, R Kshirsagar, R Vishwakarma and VS Chauhan

Piramal Life Sciences Ltd., 1, Nirlon Complex, Off. Western Express Highway, Goregaon (East), Mumbai –400 063

*Corresponding Author E-mail:  ashish.suthar@piramal.com

 

ABSTRACT

New naphthalene derivatives 4,7,8-Trimethoxy-naphthalene-2-carboxylic acid and 6-Hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde were isolated from the aerial part plant of Heliotropium ovalifolium Forssk.. Their structures were elucidated on the basis of various spectroscopic methods.

 

KEYWORDS: Heliotropium ovalifolium; 4,7,8-Trimethoxy-naphthalene-2-carboxylic acid and 6-Hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde; Spectroscopic methods

 

 


 

INTRODUCTION:

1. Plant:

The aerial parts of the herb were collected in July 2006 from Keshavshristi, Dist – Thane of Maharashtra, India and were authenticated by Natural Products - Botany, Piramal Life Sciences Ltd., Mumbai, India and a voucher specimen (No. 041005) has been deposited in the herbarium of the Piramal Life sciences Ltd.

 

2. Uses in traditional medicine:

Heliotropium ovalifolium Forssk. (Boraginaceae) was used externally and internally to treat syphilitic ulcers as per ancient literature. It is also frequently used as a analgesic and anti-inflammatory. In Kenya, the leaves are chewed as a substitute for tobacco1-3. The herb has been also reported for anti-inflammatory activity by inhibiting specific IL- 6 pro-inflammatory cytokine, along with newly isolated naphthalene derivatives (1-2) isolated 4.

 

3. Extraction and Isolation:

The aerial parts of the herb (1.2 kg) were extracted with DCM: MeOH (1:1) at room temperature to obtain 50 g of crude extract, and treated with petroleum ether in separating funnel to facilitate liquid-liquid fractionation..

 

The petroleum ether soluble fraction (26 g) was subjected to Si-gel CC with petroleum ether – acetone (by increasing percentage of acetone to increase polarity) - as eluent to afford 9-pooled fractions. Two active fractions were further subjected to analytical high performance liquid chromatography (HPLC) evaluation and then subjected to preparative HPLC on a 250 X 16 mm, Knauer Reverse phase C18, 5 m semi preparative column using gradient mobile phase of acetonitrile and water (Time/ % ACN: 0/10, 35/100, 40/100, 42/10, 55/10) at a flow rate of 15 ml/ min and UV detection at 240 nm which provided compound 1 which was characterized as 4,7,8-Trimethoxy-naphthalene-2-carboxylic acid (80 mg) with HPLC purity: 99.49 % and compound 2 which was characterized as 6-Hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde with HPLC purity: 99.50 % (56 mg).

 

4. Previously isolated classes of constituents:

Helifoline, Retronecine, Heliophenanthrone, Heliotropamide, Heliotropinone A, Heliotropinone B, Supinine  5 - 8.

 

5. Newly isolated constituents:

Compound 1: 4,7,8-Trimethoxy-naphthalene-2-carboxylic acid (Fig. 1) (80 mg from 1.2 kg of dried material): white powder; UV max (MeOH): 270, 326, 362 nm; IR bands (KBr): 3508, 3211, 2937, 1710, 1621, 1473, 1354, 1282 and 1077cm−1; Negative MS: m/z [M-1] −261 (100%), 231, 165, 112, Positive MS: m/z [M+Na]+ − 285(100%), 231, 203, 165 (calcd. for C14H14O5, 262).

 

Fig.1.  4,7,8-Trimethoxy-naphthalene-2-carboxylic acid

 

Table 1: 1H NMR and 13C NMR data for 1 (300 MHz, CDCl3, J in Hz and δ in ppm)

C

δC

δH

Dept –135

1H–1H COSY

HMBC

1

104.8

7.42

(1H,d, J 1.2)

CH

 

C- 2, 3, 9

2

122.3

 

CQ

 

 

3

124.7

8.15

(1H,d, J 1.2)

CH

 

C- 1, 2, 4, 10

4

127.1

 

CQ

 

 

5

125.1

7.65

(1H, d, J 9.0)

CH

H6

C- 4, 6, 10

6

118

7.32

(1H, t, J 13.8)

CH

H5

C- 5, 7, 9, 10

7

140.1

 

CQ

 

 

8

154.5

 

CQ

 

 

9

130.3

 

CQ

 

 

10

148.8

 

CQ

 

 

2- COOH

167.2

 

CQ

 

 

4-OCH3

52.2

3.98 (3H, s)

CH3

 

C-4

7-OCH3

62.8

3.92 (3H, s)

CH3

 

C-7

8-OCH3

56.1

4.08 (3H, s)

CH3

 

C-8

CQ- Quaternary Carbon

 

 

Compound 2: 6-Hydroxy-5,7-dimethoxy-naphthalene-2-carbaldehyde (Fig. 2) (56 mg from 1.2 kg of dried material): white powder; UV max (MeOH): 270, 326, 362 nm; IR bands (KBr): 3487, 2943, 2841, 1730, 1680 and 1350 cm−1; Negative LC-MS: m/z [M-1] −231 (100%), 177, 110; Positive LC-MS: m/z [M+Na]+ − 255 (100%), [M+1] − 233, 201, 173, 145 (calcd. for C13H12O4, 232).

 

Fig. 2. Some HMBC correlations of 4,7,8-Trimethoxy-naphthalene-2-carboxylic acid

 

Fig. 3. Structure of 6-Hydroxy-5, 7-dimethoxy-naphthalene-2-carbaldehyde.

 

Fig. 4. Some HMBC correlations of 6-Hydroxy-5, 7-dimethoxy-naphthalene-2-  carbaldehyde

 

Table 2: 1H NMR and 13C NMR data for 2 (500 and 300 MHz, CDCl3, J in Hz and δ in ppm)

C

δC

δH

Dept –135

1H–1H COSY

HMBC

1

129.9

7.86

(1H,s, J 1.2)

CH

 

C- 3, 8, 9, 10, CHO

2

149.9

 

CQ

 

 

3

127.4

7.71

(1H,d, J 8.5)

CH

 

C- 1, 2, 5, 9

4

118.2

7.36

(1H, d, J 9.0)

CH

 

C- 2, 5, 9, 10

5

140.5

 

CQ

 

 

6

132.6

 

CQ

 

 

7

155.4

 

CQ

 

 

8

100.6

7.30

(1H, t, J 11.0)

CH

 

C- 1, 7, 9, 10, CHO

9

130.2

 

CQ

 

 

10

123.4

 

CQ

 

 

2- CHO

191.7

10.02 (1H, s)

CH

 

 

5-OCH3

62.6

3.93 (3H, s)

CH3

 

C-5, 7-OCH3

7-OCH3

56.1

4.1 (3H, s)

CH3

 

C-7, 5-OCH3

6-OH

132.6

6.50 (1H, s)

 

 

 

CQ- Quaternary Carbon

 

ACKNOWLEDGEMENTS:

Special thanks to Natural products – Botany Deptt. for the collection and identification of the plant and the Analytical Sciences, Piramal Life Sciences, for recording IR, LC-MS and NMR spectra.

 

REFERENCES:

1.       Burkill HM., The useful plants of West Tropical Africa. 2nd Edition. Volume 1,   Families A–D. Royal Botanic Gardens, Kew, Richmond-United Kingdom. 1985; 960.

2.       Schmelzer GH., Gurib-Fakim A. Prota 11: Medicinal plants / Plantes médicinales PROTA, Wageningen-Netherlands. 2006.

3.       Getahun A. Some common medicinal and poisonous plants used in Ethiopian folk medicine. Faculty of Science, Addis Ababa University, Addis Ababa-Ethiopia. 1976; 63.

4.       Kulkarni-Almeida A, Suthar A, Goswami H, Vishwakarma R, Chauhan VS, Balakrishnan A, Sharma S. Phytomedicine 2008; 15: 1079.

5.       Creeper JH, Mitchell AA, Jubb TF, Colegate SM. Australian Veterinary Journal 1999; 77 (6): 401.

6.       Guilet D, Guntern A, Ioset JR, Queiroz EF, Ndjoko K, Foggin CM, Hostettmann K. J Nat Products 2003; 66 (1): 17.

7.       Guntern A, Ioset JR, Queiroz EF, Foggin CM, Hostettmann K. Phytochemistry 2001; 58 (4): 631.

8.       Guntern A, Ioset JR, Queiroz EF, Sandor P, Foggin CM, Hostettmann K. J Nat Products 2003: 66 (12): 1550.

 

 

 

Received on 09.10.2009        Modified on 29.10.2009

Accepted on 17.11.2009        © AJRC All right reserved

Asian J. Research Chem. 2(4):Oct.-Dec. 2009 page 571-573